An Open-label, fixed-sequence, 3-period, 3-treatment, Crossover Study to Assess the Effects of Rifampin on Pharmacokinetics of NKTR-118 in Healthy Subjects.
Study in healthy volunteers to investigate the effects of Rifampin on the Pharmacokinetics of NKTR-118.